Skip to content

Products

PRN1371

PRN1371

Specifications of PRN1371
CAS No.1802929-43-6
Molecular FormulaC26H30Cl2N6O4
Purity99%
GradeIndustrial Grade
AppearancePowder
Price

Price on request

Trade TermsFOB Qingdao (other Incoterms on request)

PRN1371 is an irreversible covalent inhibitor of FGFR1-4 developed for FGFR-altered solid tumours such as urothelial carcinoma.

Related Products

AP-811
AP-811

CAS: 124833-45-0

Raw API: $1,098/g (Bulk powder); Tablets: $1,373/g (Custom dosage (+25% over raw API)) FOB

Details
ASP5878

CAS: -

Raw API: $284/g (Bulk powder); Tablets: $355/g (Custom dosage (+25% over raw API)) FOB

Details
AZD4547
AZD4547

CAS: 1035270-39-3

Raw API: $200/g (Bulk powder); Tablets: $250/g (Custom dosage (+25% over raw API)) FOB

Details
Dabogratinib (TYRA-300)
Dabogratinib (TYRA-300)

CAS: -

Raw API: $1,964/g (Bulk powder); Tablets: $2,454/g (Custom dosage (+25% over raw API)) FOB

Details